CLINICAL_TRIALS ClinicalTrials.gov record update

ATLAS-PEDS: An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03974113
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-09-29T00:06:11.963098+00:00
Published At: 2026-09-28T00:00:00+00:00
Record Updated At: 2026-09-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hemophilia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-09-28"
protocolSection.identificationModule.nctId: "NCT03974113"
protocolSection.identificationModule.officialTitle: "ATLAS-PEDS: An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.